InfuSystem Holdings, Inc.

AMEX:INFU

Medical - Instruments & Supplies

Healthcare
$14.67 +4.00%

+$0.35 today

Market cap
$293.89M
Beta
1.42
P/E (TTM)
23.2
EPS (TTM)
$0.39
52W Low $5.38High $11.04

Volume 0.16M

Average 0.16M

INFU Operating Cash Flow

Cash generated by the company's core business operations during the period.

InfuSystem Holdings, Inc.AMEX: INFU

Operating Cash Flow · Q1 FY2026 · quarter ended Mar 2026

Operating cash flow dips below year-ago levels

Q1 FY2026 operating cash flow of $970K fell 45.5% year over year, behind the +7.9% change in trailing-twelve-month operating cash flow. Sequentially, it fell 86.4% from the prior quarter. Over 3 fiscal years it compounded at +11.7% a year.

Context

  • Operating cash flow amounted to 17.0% of revenue in FY2025, up 1.8 pp from a year earlier.
  • Operating cash flow increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -45.5% toward the trailing-twelve-month pace of +7.9%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$970K-86.4% QoQ
Last fiscal yearDec 2025
$24.41M+19.3% YoY
LTMMar 2026
$23.6M+7.9% YoY
Operating Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-45.5%——
1 year+19.3%——
3-year CAGR+11.7%——
5-year CAGR——
10-year CAGR——

Operating Cash Flow history

USD · from the cash flow

Latest · FY2025
24.41M USD
Year-over-year change
+19.3%
4-year CAGR
+7.4%

Operating Cash Flow vs competitors

How INFU compares with its peers on the latest reported figures

  • INFU's LTM Mar 2026 operating cash flow of $23.6M is the 2nd largest of the 3 companies compared; the peer median is $118.54M.
  • Its year-over-year change of +7.9% is the lowest of 3, against a peer median of +254.9%.
  • Operating cash flow amounts to 16.6% of revenue for INFU, versus a peer median of 6.3%.
INFU Competitors Peer median
Operating Cash Flow for INFU and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ICUIICU Medical, Inc.LTM Jun 2026$236.37M +70.3%—10.9%
INFUInfuSystem Holdings, Inc.LTM Mar 2026$23.6M +7.9%+11.7%16.6%
KRMDKORU Medical Systems, Inc.LTM Mar 2026$714.54K +439.5%—1.7%
Peer median (excluding INFU) $118.54M+254.9%—6.3%

Competitors are the stored peer set for INFU. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income1.42M18K872K2.35M6.63M
Depreciation & Amortization14.63M13.36M12.51M12.5M13.29M
Deferred Income Tax(153K)19K633K1.92M2.73M
Stock-Based Compensation6.4M3.83M4.07M4.46M4.36M
Change in Working Capital(2.69M)385K(5.56M)652K(94K)
Accounts Receivables829K(1.15M)(2.36M)(701K)263K
Inventory(864K)(882K)(1.58M)(126K)1.14M
Accounts Payables(2.36M)2.94M2.42M(676K)(708K)
Other Working Capital(294K)(522K)(4.03M)2.16M(789K)
Other Non-Cash Items(1.29M)(90K)(1.3M)(1.42M)(2.51M)
Operating Cash Flow18.32M17.52M11.22M20.46M24.41M
Capital Expenditures(16.66M)(15.08M)(11.12M)(17.83M)(560K)
Acquisitions (Net)(7.98M)3.6M4.38M4.59M(1.41M)
Purchases of Investments0(14.09M)000
Sales of Investments010.5M000
Other Investing Activities3.32M3.6M4.38M(12.15M)(4.82M)
Investing Cash Flow(21.32M)(11.48M)(6.73M)(13.24M)(6.79M)
Debt Repayment(5.47M)(13K)(3.95M)(5.32M)(4.32M)
Common Stock Issued0000335K
Common Stock Repurchased(1.73M)(6.65M)(1.31M)(2M)(10.97M)
Dividends Paid00000
Other Financing Activities738K605K835K387K0
Financing Cash Flow(6.46M)(6.06M)(4.42M)(6.92M)(14.96M)
Effect of Forex Changes00000
Net Change in Cash(9.46M)(21K)66K296K2.66M
Free Cash Flow1.66M2.44M106K2.63M23.85M

InfuSystem Holdings, Inc.

AMEX:INFU

Intrinsic Alpha fair value

Locked

Current Price

$14.67

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.